Marsit et al postulated that inactivation of the CDH1 gene by hypermethylation may lead to a less biologically aggressive tumor phenotype and greater sensitivity to treatment thereby providing a survival advantage [36]. This evidence concerns the gene CDH1 and neoplasm.